Want to join the conversation?
Analyst Robert McEwen Willoughby asks if $LH's latest acquisition Sequenom will add to earnings in the first year itself. CEO David King says the company expects it to be accretive in the first year, though not materially in year one. "We expect longer term that it will be a significant contributor to earnings growth," he says.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?